𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes

✍ Scribed by Dr. Per Boye Hansen; Hans E. Johnsen; Erik Hippe; Eva Hellström-Lindberg; Elisabeth Ralfkiaer

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
720 KB
Volume
44
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of severe aplastic anemia with
Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin
✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti

Combination Therapy With Recombinant Hum
Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia
✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

Effect of recombinant human granulocyte
Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia
✍ Mart�nez-Jaramillo, Guadalupe; G�mez-Morales, Enrique; Mayani, Hector 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The hematopoietic system in patients with aplastic anemia (AA) shows both quantitative and qualitative deficiencies, i.e., reduced numbers of hematopoietic progenitor cells (HPC) and impaired HPC proliferation in long-term marrow cultures (LTMC). Since recombinant human granulocyte macrophage-colony

Recombinant human granulocyte-macrophage
Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: Detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery
✍ Fink, Franz-Martin ;Maurer-Dengg, Kathrin ;Fritsch, Gerhard ;Mann, Georg ;Zoubek 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

## Abstract Cycling intensive chemotherapy currently used to treat pediatric solid tumors induces severe neutropenia. Prolonged neutropenia is a major risk factor for septic death which occurs in up to 5% of febrile or septic neutropenic episodes. We treated 18 neutropenic pediatric cancer patients